{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:08:13Z","timestamp":1789610893201,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.schres.2016.09.026","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T17:51:29Z","timestamp":1476899489000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"special_numbering":"C","title":["Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-na\u00efve patients with nonaffective psychosis"],"prefix":"10.1016","volume":"179","author":[{"given":"Anne Marie","family":"Greenhalgh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Gonzalez-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemente","family":"Garcia-Rizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4128-8955","authenticated-orcid":false,"given":"Emilio","family":"Fernandez-Egea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Bernardo","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.schres.2016.09.026_bb0005","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archgenpsychiatry.2010.100","article-title":"Birth weight, schizophrenia, and adult mental disorder: is risk confined to the smallest babies?","volume":"67","author":"Abel","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2016.09.026_bb0010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","author":"American Diabetes Association and American Psychiatric Association","year":"2004","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.schres.2016.09.026_bb0015","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4088\/JCP.v65n1007","article-title":"Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients","volume":"65","author":"Arranz","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2016.09.026_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/YIC.0b013e3283377850","article-title":"Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis","volume":"25","author":"Basoglu","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.schres.2016.09.026_bb0025","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1176\/appi.ajp.2011.11010048","article-title":"Diagnostic shifts during the decade following first admission for psychosis","volume":"168","author":"Bromet","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2016.09.026_bb0030","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1021\/pr300459d","article-title":"Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone","volume":"11","author":"Cai","year":"2012","journal-title":"J. Proteome Res."},{"issue":"7","key":"10.1016\/j.schres.2016.09.026_bb0035","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1176\/appi.ajp.159.7.1080","article-title":"Obstetric complications and schizophrenia: historical and meta-analytic review","volume":"159","author":"Cannon","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2016.09.026_bb0040","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1469-7610.2011.02443.x","article-title":"Two-year diagnostic stability in early-onset first-episode psychosis","volume":"52","author":"Castro-Fornieles","year":"2011","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"3-4","key":"10.1016\/j.schres.2016.09.026_bb0045","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/biomet\/37.3-4.256","article-title":"The comparison of percentages in matched samples","volume":"37","author":"Cochran","year":"1950","journal-title":"Biometrika"},{"issue":"1-3","key":"10.1016\/j.schres.2016.09.026_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.schres.2015.05.004","article-title":"Metabolic syndrome in drug-na\u00efve and drug-free patients with schizophrenia and in their siblings","volume":"166","author":"Darcin","year":"2015","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2016.09.026_bb0055","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.pnpbp.2010.06.011","article-title":"Insulin resistance and metabolic profile in antipsychotic naive schizophrenia patients","volume":"34","author":"Dasgupta","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2016.09.026_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"issue":"1-3","key":"10.1016\/j.schres.2016.09.026_bb0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2008.04.017","article-title":"Glucose abnormalities in the siblings of people with schizophrenia","volume":"103","author":"Fernandez-Egea","year":"2008","journal-title":"Schizophr. Res."},{"issue":"1-3","key":"10.1016\/j.schres.2016.09.026_bb0070","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.schres.2007.10.002","article-title":"Parental history of type 2 diabetes in patients with nonaffective psychosis","volume":"98","author":"Fernandez-Egea","year":"2008","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2016.09.026_bb0075","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1192\/bjp.bp.108.052605","article-title":"Metabolic profile of antipsychotic-naive individuals with non-affective psychosis","volume":"194","author":"Fernandez-Egea","year":"2009","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2016.09.026_bb0080","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/schbul\/sbs134","article-title":"Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? A historical and contemporary view","volume":"39","author":"Fernandez-Egea","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2016.09.026_bb0085","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","article-title":"Meta-analysis of oxidative stress in schizophrenia","volume":"74","author":"Flatow","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2016.09.026_bb0090","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 2011","author":"Higgins","year":"2011"},{"issue":"2","key":"10.1016\/j.schres.2016.09.026_bb0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1463-1326.2005.00495.x","article-title":"Association between antipsychotic drugs and diabetes","volume":"8","author":"Holt","year":"2006","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.schres.2016.09.026_bb0100","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1096\/fj.15-279810","article-title":"Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic \u03b2-cell function via glycogen synthase kinase-3\u03b2","volume":"30","author":"Jurczyk","year":"2016","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.schres.2016.09.026_bb0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/jhg.2013.116","article-title":"Genetic association study between the detected risk variants based upon type II diabetes GWAS and psychotic disorders in the Japanese population","volume":"59","author":"Kajio","year":"2014","journal-title":"J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.schres.2016.09.026_bb0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5455\/bcp.20130713091100","article-title":"Intracellular Adhesion Molecule (ICAM-1), Vascular Cell Adhesion Molecule (VCAM-1) and E-selectin levels in first episode schizophrenic patients","volume":"23","author":"Kavzoglu","year":"2013","journal-title":"Bull. Clin. Psychopharmacol."},{"issue":"2-3","key":"10.1016\/j.schres.2016.09.026_bb0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.schres.2008.09.023","article-title":"Differences in glucose tolerance between deficit and nondeficit schizophrenia","volume":"107","author":"Kirkpatrick","year":"2009","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2016.09.026_bb0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/schbul\/sbq058","article-title":"Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits?","volume":"38","author":"Kirkpatrick","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2016.09.026_bb0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3371\/CSRP.KIMI.031513","article-title":"Schizophrenia: a systemic disorder","volume":"8","author":"Kirkpatrick","year":"2014","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"5","key":"10.1016\/j.schres.2016.09.026_bb0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0706743716644765","article-title":"Dopamine 2 receptor genes are associated with raised blood glucose in schizophrenia","volume":"61","author":"Lawford","year":"2016","journal-title":"Can. J. Psychiatr."},{"issue":"10","key":"10.1016\/j.schres.2016.09.026_bb0135","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.2337\/db10-0385","article-title":"Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood","volume":"59","author":"Li","year":"2010","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2016.09.026_bb0140","first-page":"S17","article-title":"Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis","volume":"6","author":"Liu","year":"2013","journal-title":"BMC Med. Genet."},{"issue":"10","key":"10.1016\/j.schres.2016.09.026_bb0145","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S2213-8587(15)00279-X","article-title":"Association between type 2 diabetes and prenatal exposure to the Ukraine famine of 1932\u201333: a retrospective cohort study","volume":"3","author":"Lumey","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"10.1016\/j.schres.2016.09.026_bb0150","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2016.09.026_bb0155","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.biopsych.2012.09.007","article-title":"Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects","volume":"73","author":"Miller","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2016.09.026_bb0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3371\/CSRP.MICU.020813","article-title":"C-reactive protein levels in schizophrenia: a review and meta-analysis","volume":"7","author":"Miller","year":"2014","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.schres.2016.09.026_bb0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.psychres.2016.01.077","article-title":"Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism","volume":"238","author":"Misiak","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2016.09.026_bb0170","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(89)91392-5","article-title":"Family history of type 2 diabetes in schizophrenic patients","volume":"1","author":"Mukherjee","year":"1989","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.schres.2016.09.026_bb0175","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.clinthera.2004.12.003","article-title":"Metabolic risk during antipsychotic treatment","volume":"26","author":"Newcomer","year":"2004","journal-title":"Clin. Ther."},{"issue":"1-2","key":"10.1016\/j.schres.2016.09.026_bb0180","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.schres.2015.07.053","article-title":"Metabolic syndrome and aerobic fitness in patients with first-episode schizophrenia, including a 1-year follow-up","volume":"168","author":"Nyboe","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2016.09.026_bb9000","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jpsychires.2016.02.015","article-title":"Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives","volume":"77","author":"Padmanabhan","year":"2016","journal-title":"J. Psychiatr. Res."},{"issue":"1-3","key":"10.1016\/j.schres.2016.09.026_bb0185","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.schres.2010.05.010","article-title":"Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia","volume":"121","author":"Padmavati","year":"2010","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2016.09.026_bb0190","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.psychres.2015.07.041","article-title":"Parameters of glucose and lipid metabolism at the fasted state in drug-na\u00efve first-episode patients with psychosis: evidence for insulin resistance","volume":"229","author":"Petrikis","year":"2015","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.schres.2016.09.026_bb0195","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2016.09.026_bb0200","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0447.2008.01158.x","article-title":"Diabetes and schizophrenia \u2013 effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia","volume":"117","author":"Saddichha","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.schres.2016.09.026_bb0205","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.57.6.593","article-title":"Congruence of diagnoses 2years after a first-admission diagnosis of psychosis","volume":"57","author":"Schwartz","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1-3","key":"10.1016\/j.schres.2016.09.026_bb0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.schres.2008.02.013","article-title":"Are metabolic indices different between drug-naive first-episode psychosis patients and healthy controls?","volume":"102","author":"Sengupta","year":"2008","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2016.09.026_bb0215","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","article-title":"Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia","volume":"24","author":"Spelman","year":"2007","journal-title":"Diabet. Med."},{"issue":"5","key":"10.1016\/j.schres.2016.09.026_bb0220","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.294.5.557","article-title":"Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959\u20131961","volume":"294","author":"St Clair","year":"2005","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.schres.2016.09.026_bb0225","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/archpsyc.1992.01820120071010","article-title":"Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944\u20131945","volume":"49","author":"Susser","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2016.09.026_bb0230","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1073\/pnas.1215626110","article-title":"Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century","volume":"110","author":"Thurner","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2-3","key":"10.1016\/j.schres.2016.09.026_bb0235","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.schres.2012.11.011","article-title":"The prevalence of diabetes mellitus is increased in relatives of patients with a non-affective psychotic disorder","volume":"143","author":"Van Welie","year":"2013","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.schres.2016.09.026_bb0240","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1176\/appi.ajp.2007.07020233","article-title":"Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia","volume":"164","author":"Venkatasubramanian","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2016.09.026_bb0245","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archpsyc.58.1.48","article-title":"Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood","volume":"58","author":"Wahlbeck","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2016.09.026_bb0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/0976-3147.143182","article-title":"Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia, before and after antipsychotic treatment","volume":"6","author":"Wani","year":"2015","journal-title":"J. Neurosci. Rural Pract."},{"issue":"1-3","key":"10.1016\/j.schres.2016.09.026_bb0255","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.schres.2006.09.002","article-title":"Minor physical anomalies in schizophrenia: a meta-analysis","volume":"89","author":"Weinberg","year":"2007","journal-title":"Schizophr. Res."},{"issue":"24","key":"10.1016\/j.schres.2016.09.026_bb0260","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1001\/jama.2008.886","article-title":"Birth weight and risk of type 2 diabetes: a systematic review","volume":"300","author":"Whincup","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.schres.2016.09.026_bb0265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.schres.2013.07.051","article-title":"The comparison of glycometabolism parameters and lipid profiles between drug-naive, first-episode schizophrenia patients and healthy controls","volume":"150","author":"Wu","year":"2013","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.schres.2016.09.026_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024129","article-title":"Minor physical anomalies in patients with schizophrenia, unaffected first-degree relatives, and healthy controls: a meta-analysis","volume":"6","author":"Xu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2016.09.026_bb0280","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.psyneuen.2015.09.005","article-title":"Glucose disturbances in first-episode drug-na\u00efve schizophrenia: relationship to psychopathology","volume":"62","author":"Zhang","year":"2015","journal-title":"Psychoneuroendocrinology"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416304352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416304352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T04:16:27Z","timestamp":1549772187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996416304352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":56,"alternative-id":["S0920996416304352"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2016.09.026","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-na\u00efve patients with nonaffective psychosis","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2016.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}